The human protein atlas (HPA) analysis was used to observe that ACTL6A protein expressions in ovarian cancer (https://www.proteinatlas.org/ENSG00000136518-ACTL6A/pathology/ovarian+cancer#Quantity, data obtained on 1 December 2022). This evidence concerns the gene ACTL6A and ovarian carcinoma.